Profile
The South East Asia Infectious Disease Clinical Research Network (SEAICRN) is a collaborative partnership between hospitals and research institutions within Thailand, Vietnam and Indonesia that was first formed in September 2005.
SEAICRN’s main focus is to improve patient care and human health through conducting clinical research, where protocol-based studies following international standards are developed and implemented. Research areas that address current pressing public health issues that will significantly improve patient care and human health are prioritised.
The Network provides ample and diverse opportunities for scientists and research team members from participating hospitals and institutions. These opportunities include short and long term scholarships, study-specific seminars and workshops. Overall, the goal of these activities is to further strengthen the individual and their team’s capacity in conducting high quality clinical research.
The University of Oxford, Center for Tropical Medicine, Nuffield Department of Medicine, provides technical leadership and administrative support to the Network.
The World Health Organization participates in the SEAICRN as an observer.
SEAICRN's Main Goals
SEAICRN strives to improve patient care and human health by advancing scientific knowledge and encouraging collaborative clinical research. Furthermore, it endeavours to boost the research capacity of participating institutions and individuals within the Network.
SEAICRN's Main Values
Collaboration between different institutions to collectively improve scientific knowledge and global public health.
Commitment to improve patient management by conducting the highest quality clinical research at the highest ethical standard.
Coordination of multi-centered, protocol-based clinical research while respecting all relevant regulations and policies.
Sharing of information and knowledge publicly in a timely fashion, bringing scientific insight and improved capacity to all Network partners.
SEAICRN's Funding
SEAICRN is funded by an international consortium including:
- The US National Institutes of Health’s National Institute of Allergy and Infectious Diseases, USA
- The Wellcome Trust, UK.
The Network does not accept financial support from pharmaceutical or other for-profit organizations.